|
Harry
W. Diehl discovered
cetyl myristoleate (CMO) in 1964 in his home laboratory. While he was
employed then at the National Institutes of Health in Bethesda,
Maryland, CMO was his personal, off-duty project. He received a U.S.
patent on CMO initially in 1977 (U.S. Patent #4,049,824). He later
received an entirely new patent in 1996 (U.S. Patent #5,569,676). EHP Products is now the owner of this patent, which is available online at www.uspto.gov/patft/index.html. Mr.
Diehl tried unsuccessfully to get some large companies, such as Pfizer
and Merck, to accept his discovery for research and marketing but they
declined, possibly due to rules concerning patents on natural
products. Despite owning these two patents, Mr. Diehl was unfamiliar
with the marketing of natural products, so, unfortunately, CMO
remained unknown to users of natural products until 1996.
EHP Products, Inc.
was founded in 1995 by Elaine Parrish, Mr. Diehl's daughter. Mr. Diehl
wanted to assure a way for this astounding discovery to reach the
public in his original oil formula, and Elaine was willing to form a
company to distribute his formula of cetyl myristoleate which EHP
Products Inc. tradenamed Myristinâ. In
1996, Mr. Diehl assigned his most recent patent to EHP Products. EHP is the only company in the world to market a 40% CMO softgel.
EHP Products is proud to have many M.D.'s, D.O.'s, N.D.'s, D.C.'s, D.P.M's, D.V.M's, and other healthcare professionals among its many customers. Myristinâ Dietary
Supplement is marketed in the United States and internationally. EHP
ships frequently to such countries as Canada, United Kingdom, France,
The Netherlands, South Africa, and Australia.
EHP Products Inc. also markets other quality dietary supplements such
as: Myrist-Aid, Myristin Topical
Cream, CoEnzyme Q10, Grape Seed
Extract, Milk Thistle Extract, and
Salmon Oil. To
order these products at internet special prices, go to the order
form.
|
|